Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal.
Fabre Elizabeth, Rivera Caroline, Mordant Pierre, +5 more·Thoracic cancer
BACKGROUND: Induction chemotherapy (ICT) is supposed to reduce the risk of micrometastatic progression and improve resectability of non-small cell lung cancer (NSCLC). However, best indications for ICT strategy remain unclear in published meta-analyses. Based on this observation, an evaluation of daily practice is of i…